ZA200108055B - C10 ester substituted taxanes as antitumor agents. - Google Patents

C10 ester substituted taxanes as antitumor agents. Download PDF

Info

Publication number
ZA200108055B
ZA200108055B ZA200108055A ZA200108055A ZA200108055B ZA 200108055 B ZA200108055 B ZA 200108055B ZA 200108055 A ZA200108055 A ZA 200108055A ZA 200108055 A ZA200108055 A ZA 200108055A ZA 200108055 B ZA200108055 B ZA 200108055B
Authority
ZA
South Africa
Prior art keywords
substituted
pyridyl
thienyl
furyl
coo
Prior art date
Application number
ZA200108055A
Other languages
English (en)
Inventor
Robert A Holton
Original Assignee
Univ Florida State Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Florida State Res Found filed Critical Univ Florida State Res Found
Publication of ZA200108055B publication Critical patent/ZA200108055B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65DCONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D83/00Containers or packages with special means for dispensing contents
    • B65D83/14Containers or packages with special means for dispensing contents for delivery of liquid or semi-liquid contents by internal gaseous pressure, i.e. aerosol containers comprising propellant for a product delivered by a propellant
    • B65D83/75Aerosol containers not provided for in groups B65D83/16 - B65D83/74
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA200108055A 2000-02-02 2001-10-01 C10 ester substituted taxanes as antitumor agents. ZA200108055B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17978200P 2000-02-02 2000-02-02

Publications (1)

Publication Number Publication Date
ZA200108055B true ZA200108055B (en) 2003-12-01

Family

ID=22657972

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200108055A ZA200108055B (en) 2000-02-02 2001-10-01 C10 ester substituted taxanes as antitumor agents.

Country Status (25)

Country Link
EP (1) EP1165553B1 (fr)
JP (1) JP2003522172A (fr)
CN (1) CN1380882A (fr)
AT (1) ATE432928T1 (fr)
AU (1) AU782150B2 (fr)
BG (1) BG64889B1 (fr)
BR (1) BR0104354A (fr)
CA (1) CA2368274C (fr)
CZ (1) CZ20013430A3 (fr)
DE (1) DE60138853D1 (fr)
GE (1) GEP20043323B (fr)
HU (1) HUP0600302A2 (fr)
IL (1) IL145638A (fr)
MX (1) MXPA01009905A (fr)
NO (1) NO327910B1 (fr)
NZ (1) NZ514382A (fr)
PL (1) PL202957B1 (fr)
RO (1) RO121270B1 (fr)
RU (1) RU2262506C2 (fr)
SK (1) SK13692001A3 (fr)
TR (1) TR200102858T1 (fr)
TW (1) TWI299732B (fr)
UA (1) UA75039C2 (fr)
WO (1) WO2001057032A1 (fr)
ZA (1) ZA200108055B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6649632B2 (en) 2000-02-02 2003-11-18 Fsu Research Foundation, Inc. C10 ester substituted taxanes
CA2354471A1 (fr) * 2001-07-31 2003-01-31 Florida State University Research Foundation, Inc. Taxanes substitues avec un ester en c10
SG129990A1 (en) * 2001-08-01 2007-03-20 Univ Florida State Res Found C10 ester substituted taxanes
SV2006002010A (es) 2004-02-13 2006-08-23 Univ Florida State Res Found Taxanos sustituidos con esteres de ciclopentilo en c10
EP1848423A4 (fr) * 2005-02-14 2008-12-31 Univ Florida State Res Found Compositions de taxane a substitution cyclopropyl ester en c10
US8242166B2 (en) 2008-03-31 2012-08-14 Florida State University Research Foundation, Inc. C(10) ethyl ester and C(10) cyclopropyl ester substituted taxanes

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2601675B1 (fr) * 1986-07-17 1988-09-23 Rhone Poulenc Sante Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
US5250683A (en) * 1991-09-23 1993-10-05 Florida State University Certain substituted taxanes and pharmaceutical compositions containing them
US5243045A (en) * 1991-09-23 1993-09-07 Florida State University Certain alkoxy substituted taxanes and pharmaceutical compositions containing them
IL108443A0 (en) * 1993-01-29 1994-04-12 Univ Florida State C7 taxane derivatives and pharmaceutical compositions containing them
ES2164100T3 (es) * 1993-03-22 2002-02-16 Univ Florida State Taxanos con una cadena lateral de piridina sustituida.
EP0689436B1 (fr) * 1993-03-22 2003-11-26 Florida State University Taxanes ne pas presentant un groupe c-9 oxo et compositions pharmaceutiques contenant de tels composes
ATE195421T1 (de) * 1993-03-22 2000-09-15 Univ Florida State Taxane mit amino-substituierter seitenkette
US6100411A (en) * 1994-10-28 2000-08-08 The Research Foundation Of State University Of New York Taxoid anti-tumor agents and pharmaceutical compositions thereof
WO1996013495A1 (fr) * 1994-10-28 1996-05-09 The Research Foundation Of State University Of New York Derives taxoides, leur preparation et leur utilisation en tant qu'agents antitumoraux
US5795909A (en) * 1996-05-22 1998-08-18 Neuromedica, Inc. DHA-pharmaceutical agent conjugates of taxanes
DE69703294T2 (de) * 1996-05-22 2001-05-17 Protarga Inc Zusammensetzungen die konjugate von cis-docosahexaenoic-säure und taxotere enthalten
WO1999032473A1 (fr) * 1997-12-19 1999-07-01 Kabushiki Kaisha Yakult Honsha Derives de taxane
JP2003026673A (ja) * 1999-03-05 2003-01-29 Asahi Kasei Corp 骨形成促進剤

Also Published As

Publication number Publication date
ATE432928T1 (de) 2009-06-15
PL351380A1 (en) 2003-04-07
EP1165553B1 (fr) 2009-06-03
EP1165553A1 (fr) 2002-01-02
MXPA01009905A (es) 2003-08-20
SK13692001A3 (sk) 2002-07-02
CZ20013430A3 (cs) 2002-04-17
WO2001057032A1 (fr) 2001-08-09
UA75039C2 (en) 2006-03-15
NO20014754D0 (no) 2001-10-01
RO121270B1 (ro) 2007-02-28
CA2368274A1 (fr) 2001-08-09
NO20014754L (no) 2001-11-29
TR200102858T1 (tr) 2002-12-23
GEP20043323B (en) 2004-02-10
BG105965A (en) 2002-07-31
DE60138853D1 (de) 2009-07-16
HUP0600302A2 (en) 2006-07-28
TWI299732B (en) 2008-08-11
AU3480901A (en) 2001-08-14
NO327910B1 (no) 2009-10-19
JP2003522172A (ja) 2003-07-22
RU2262506C2 (ru) 2005-10-20
AU782150B2 (en) 2005-07-07
NZ514382A (en) 2004-05-28
CN1380882A (zh) 2002-11-20
BG64889B1 (bg) 2006-08-31
IL145638A (en) 2011-05-31
PL202957B1 (pl) 2009-08-31
IL145638A0 (en) 2002-06-30
BR0104354A (pt) 2002-01-02
CA2368274C (fr) 2009-10-13

Similar Documents

Publication Publication Date Title
CA2368993C (fr) Taxanes substitues par ester en c7 utilises comme agents anticancereux
ZA200108052B (en) C10 heterosubstituted acetate taxanes as antitumor agents.
US7226944B2 (en) Taxanes having a C7 carbonate substituent
AU782028B2 (en) C10 carbonate substituted taxanes as antitumor agents
US20040087547A1 (en) C7 heterosubstituted acetate taxane compositions
US6649632B2 (en) C10 ester substituted taxanes
EP1165553B1 (fr) Taxanes substitues par un ester en c10 comme agents antitumoraux
EP1165551A1 (fr) Taxanes substitues par carbamoyloxy au niveau de c10 en tant qu'agents antitumoraux
NZ514410A (en) C7 carbamoyloxy substituted taxanes as antitumor agents